Concepedia

Hirotaka Numaguchi

HN

8

Publications

283

Citations

8

H-Index

1995

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD K.K. (Japan)

Teikyo University

Juntendo University

Boehringer Ingelheim (Japan)

Hirotaka Numaguchi is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, cardiovascular disease, and pharmacology.

Top concepts

Publications per year

1995–2017

8

Publications

8

Probing the Interaction Between Inactivation Gating and<scp>d</scp>d-Sotalol Block of<i>HERG</i>

Hirotaka Numaguchi, Franklin M. Mullins, J. P. Johnson et al. · Circulation Research · 2000 · 97 citations

A sensitive mechanism for cation modulation of potassium current

Hirotaka Numaguchi, J. P. Johnson, Christina I. Petersen et al. · Nature Neuroscience · 2000 · 67 citations

, , +6

Characteristics and 1-Year Prognosis of Medically Treated Patients With Chronic Heart Failure in Japan-Chronic Heart Failure Analysis Registry in Tohoku District (CHART)-

Yoshito Koseki, Jun Watanabe, Tsuyoshi Shinozaki et al. · Circulation Journal · 2003 · 38 citations · Full text

Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib in Japanese patients with dyslipidemia

Tamio Teramoto, Masayoshi Shirakawa, Masashi Kikuchi et al. · Atherosclerosis · 2013 · 29 citations

, , +8

Lipid-modifying efficacy and tolerability of anacetrapib added to ongoing statin therapy in Japanese patients with dyslipidemia

Tamio Teramoto, Hiroyuki Daida, Katsunori Ikewaki et al. · Atherosclerosis · 2017 · 16 citations · Full text

Rows per page

1–5 of 8